2. Anti-infection Others
  3. Fungal Isotope-Labeled Compounds
  4. CYP51-IN-25

CYP51-IN-25 is a orally active broad spectrum antifungal agent with the MIC80 of 0.00625-0.05 μg/mL. is a CYP51-IN-25 is a deuterated compound with antibiotic properties. CYP51-IN-25 can inhibit the fungal CYP51 enzyme, block ergosterol synthesis, and disrupt cell membrane integrity. CYP51-IN-25 can be used for research on fungal infections.

For research use only. We do not sell to patients.

CYP51-IN-25

CYP51-IN-25 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

CYP51-IN-25 Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

CYP51-IN-25 is a orally active broad spectrum antifungal agent with the MIC80 of 0.00625-0.05 μg/mL. is a CYP51-IN-25 is a deuterated compound with antibiotic properties. CYP51-IN-25 can inhibit the fungal CYP51 enzyme, block ergosterol synthesis, and disrupt cell membrane integrity. CYP51-IN-25 can be used for research on fungal infections[1].

In Vitro

CYP51-IN-25 (Compoud C52) has a broad-spectrum antifungal activity in Candida albicans (SC 5314) (MIC80 = 0.0625 μg/mL), Candida albicans (CPCC 400616) (MIC80 = 0.0625 μg/mL), Candida tropicalis (CGMCC 2.3739) (MIC80 = 0.0625 μg/mL), Candida parapsilosis (GIM 2.190) (MIC80 = 0.0625 μg/mL), Candida glabrata (Clinical isolation) (MIC80 = 0.0125 μg/mL) (MFC = 0.5 μg/mL), Candida krusei (AS 2.1045) (MIC80 = 0.0125 μg/mL) (MFC = 0.0125 μg/mL), Cryptococcus neoformans (CGMCC 2.3161) (MIC80 = 0.0125 μg/mL) (MFC = 0.0625 μg/mL) and Aspergillus fumigatus (CGMCC 3.7795) (MIC80 = 0.025 μg/mL)[1].
CYP51-IN-25 has a lower risk of drug-drug interactions (DDI) in other CYP450 isoforms such as CYP1A2 (IC50 > 10 μg/mL), CYP2C9 (IC50 = 1.76 μg/mL), CYP2C19 (IC50 = 1.71 μg/mL), CYP2D6 (IC50 > 10 μg/mL), CYP3A4-M (IC50 = 5.11 μg/mL) and CYP3A4-T (IC50 = 6.62 μg/mL)[1].
CYP51-IN-25 maintains a favorable safety profile toward mammalian cells within the tested concentration range[1].
CYP51-IN-25 inhibits the biofilm formation of Candida glabrata (SMIC50 = 0.0625 μg/mL) and Cryptococcus neoformans (CGMCC 2.3161) (SMIC50 = 0.1625 μg/mL)[1].
CYP51-IN-25 (2 μg/mL) effectively inhibits the transformation of fungi from yeast phase to hyphal phase[1].
CYP51-IN-25 (16 μg/mL,48 h) destroys the integrity of fungal cell membranes of Candida albicans (SC 5314)[1].
CYP51-IN-25 (0.0125-0.125 μg/mL) can significantly reduce the content of ergosterol of Candida albicans (SC 5314) and Cryptococcus neoformans (CGMCC 2.3161)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

CYP51-IN-25 Related Antibodies
In Vivo

CYP51-IN-25 (500 mg/kg; i.g.) has favorable safety profile under acute exposure conditions in the ICR mice female and male mice[1].
CYP51-IN-25 (100 mg/kg; i.g.; once daily; for 14 days) exhibits low cumulative toxicity under subacute exposure conditions in the ICR mice female and male mice[1].
CYP51-IN-25 (1-10 mg/kg; i.g.; once daily; for 5 days) has strong antifungal activity and prolongs the survival cycle of mice in a Candida albicans (SC 5314) infectious mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: the ICR mice female and male mice (6-8 weeks, 20-25g)[1]
Dosage: 500 mg/kg
Administration: Oral gavage (i.g.) 200 μL
Result: Did not cause significant changes in the weight and did not cause significant pathological changes in major organs of the infectious mice.
Animal Model: the ICR mice female and male mice (6-8 weeks, 20-25g)[1]
Dosage: 100 mg/kg
Administration: Oral gavage (i.g.); once daily; for 14 days
Result: Keeped the weight of mice fluctuating within a physiological range and did not cause significant histopathological changes in the liver and kidneys of the infectious mice.
Animal Model: 1×106 (CFU)/mL Candida albicans (SC5314) injected the male ICR mice (4-6 weeks, 18-22g)[1]
Dosage: 1 mg/kg, 5 mg/kg, 10 mg/kg, fluconazole (HY-B0101) as a control group
Administration: Oral gavage (i.g.); once daily for 5 days
Result: Exhibited strong antifungal activity and significantly reduced the amount of fungi in the kidneys.
Molecular Weight

535.52

Formula

C27H22D3F5N4O2
SMILES

FC1=CC=C([C@]([C@H](C)N(C([2H])([2H])[2H])CC2=CC=C(C3=CC=C(OC(F)(F)F)C=C3)C=C2)(O)CN4C=NC=N4)C(F)=C1
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

CYP51-IN-25 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

CYP51-IN-25FungalIsotope-Labeled CompoundsantifungalCYP51ergosterolinfectionInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
CYP51-IN-25
Cat. No.:
HY-174394S
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.